These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 3858272)

  • 1. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
    Mennini G; Silecchia G; Zanna C; Cucchiara G; Spadaro G; Greco E; Basoli A; Speranza V
    Ital J Surg Sci; 1985; 15(1):37-43. PubMed ID: 3858272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
    Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G
    Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical aspects of the CEA test.
    Laurence JR; Neville AM
    Bull Cancer; 1976; 63(4):473-81. PubMed ID: 1021177
    [No Abstract]   [Full Text] [Related]  

  • 5. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers].
    Capocasale E; Contini S; Rossetti A; Del Sante G; Gregori G
    Acta Biomed Ateneo Parmense; 1985; 56(6):231-6. PubMed ID: 2940782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
    Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
    Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CA 12-5 in cancer of the digestive tract. A comparison with CA 19-9 and CEA in cancer of the pancreas and colon].
    Klapdor R; Klapdor U; Bahlo M; Dallek M; Kremer B; van Ackeren H; Schreiber HW; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1949-54. PubMed ID: 6595110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies].
    Dienst C; Clodius T; Oldörp T; Uhlenbruck G; Diehl V
    Med Klin (Munich); 1987 Jan; 82(2):45-50. PubMed ID: 3470595
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies.
    Yoshikawa T; Nishida K; Tanigawa M; Fukumoto K; Kondo M
    Digestion; 1985; 31(2-3):67-76. PubMed ID: 2581838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
    Staab HJ
    Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
    [No Abstract]   [Full Text] [Related]  

  • 12. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract]   [Full Text] [Related]  

  • 13. Estimation of carbohydrate antigen (CA) 19-9 levels in pure pancreatic juice of patients with pancreatic cancer.
    Nishida K; Tasaki N; Miyagawa H; Yoshikawa T; Kondo M
    Am J Gastroenterol; 1988 Feb; 83(2):126-9. PubMed ID: 3422536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma.
    Satake K; Kanazawa G; Kho I; Chung YS; Umeyama K
    J Surg Oncol; 1985 May; 29(1):15-21. PubMed ID: 3857396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
    McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
    Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
    [No Abstract]   [Full Text] [Related]  

  • 16. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
    Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
    Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
    Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New monoclonal antibodies in the diagnosis of gastrointestinal cancers].
    Heptner G; Domschke S; Domschke W
    Internist (Berl); 1986 Nov; 27(11):723-8. PubMed ID: 2433247
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical value of the plasma-CEA-concentrations in the primary diagnosis of malignoma of the digestive tract].
    Aver IO; Münch L; Epping J; Schmid L
    Z Gastroenterol Verh; 1976; (11):73-7. PubMed ID: 65868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.